Verfügbarkeit: The Future of HIV-1 Therapeutics

The Future of HIV-1 Therapeutics: Resistance Is Futile?

Gespeichert in:

Bibliographische Detailangaben
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	Cham [u.a.] Springer International Publishing 2015
Schriftenreihe:	Current Topics in Microbiology and Immunology 389
Schlagworte:	Medicine Drug interactions Medical virology Emerging infectious diseases Biomedicine Drug Resistance Virology Infectious Diseases Medizin Antiretrovirale Substanz HIV-Infektion Aufsatzsammlung
Online-Zugang:	TUM01 UBT01 Volltext Inhaltsverzeichnis Abstract
Beschreibung:	1 Online-Ressource (X, 254 p)
ISBN:	9783319185187
DOI:	10.1007/978-3-319-18518-7

Internformat

MARC


LEADER	00000nmm a2200000zcb4500
001	BV042544613
003	DE-604
005	20150508
007	cr\|uuu---uuuuu
008	150506s2015 \|\|\|\| o\|\|u\| \|\|\|\|\|\|eng d
020			\|a 9783319185187 \|c Online \|9 978-3-319-18518-7
024	7		\|a 10.1007/978-3-319-18518-7 \|2 doi
035			\|a (OCoLC)909073851
035			\|a (DE-599)BVBBV042544613
040			\|a DE-604 \|b ger \|e aacr
041	0		\|a eng
049			\|a DE-91 \|a DE-703
082	0		\|a 616.9041 \|2 23
084			\|a BIO 000 \|2 stub
245	1	0	\|a The Future of HIV-1 Therapeutics \|b Resistance Is Futile? \|c Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, ed.
264		1	\|a Cham [u.a.] \|b Springer International Publishing \|c 2015
300			\|a 1 Online-Ressource (X, 254 p)
336			\|b txt \|2 rdacontent
337			\|b c \|2 rdamedia
338			\|b cr \|2 rdacarrier
490	1		\|a Current Topics in Microbiology and Immunology \|v 389
650		4	\|a Medicine
650		4	\|a Drug interactions
650		4	\|a Medical virology
650		4	\|a Emerging infectious diseases
650		4	\|a Biomedicine
650		4	\|a Drug Resistance
650		4	\|a Virology
650		4	\|a Infectious Diseases
650		4	\|a Medizin
650	0	7	\|a Antiretrovirale Substanz \|0 (DE-588)4798688-8 \|2 gnd \|9 rswk-swf
650	0	7	\|a HIV-Infektion \|0 (DE-588)4203852-2 \|2 gnd \|9 rswk-swf
655		7	\|8 1\p \|0 (DE-588)4143413-4 \|a Aufsatzsammlung \|2 gnd-content
689	0	0	\|a HIV-Infektion \|0 (DE-588)4203852-2 \|D s
689	0	1	\|a Antiretrovirale Substanz \|0 (DE-588)4798688-8 \|D s
689	0		\|8 2\p \|5 DE-604
700	1		\|a Torbett, Bruce E. \|e Sonstige \|4 oth
700	1		\|a Goodsell, David S. \|d 1961- \|e Sonstige \|0 (DE-588)172557968 \|4 oth
700	1		\|a Richman, Douglas D. \|e Sonstige \|4 oth
776	0	8	\|i Erscheint auch als \|n Druckausgabe \|z 978-3-319-18517-0
830		0	\|a Current Topics in Microbiology and Immunology \|v 389 \|w (DE-604)BV022782309 \|9 389
856	4	0	\|u https://doi.org/10.1007/978-3-319-18518-7 \|x Verlag \|3 Volltext
856	4	2	\|m Springer Fremddatenuebernahme \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
856	4	2	\|m Springer Fremddatenuebernahme \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA \|3 Abstract
912			\|a ZDB-2-SBL
940	1		\|q ZDB-2-SBL_2015
999			\|a oai:aleph.bib-bvb.de:BVB01-027978619
883	1		\|8 1\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 2\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
966	e		\|u https://doi.org/10.1007/978-3-319-18518-7 \|l TUM01 \|p ZDB-2-SBL \|x Verlag \|3 Volltext
966	e		\|u https://doi.org/10.1007/978-3-319-18518-7 \|l UBT01 \|p ZDB-2-SBL \|x Verlag \|3 Volltext

Datensatz im Suchindex

_version_	1804153310407557120
adam_text	THE FUTURE OF HIV-1 THERAPEUTICS / TORBETT, BRUCE E. : 2015 TABLE OF CONTENTS / INHALTSVERZEICHNIS HIV THERAPY LOOKING TOWARDS THE FUTURE COMPUTATIONAL CHALLENGES OF STRUCTURE-BASED APPROACHES APPLIED TO HIV NUCLEOCAPSID PROTEIN: A DESIRABLE TARGET FOR FUTURE THERAPIES AGAINST HIV-1 HIV-1 INTEGRASE MULTIMERIZATION AS A THERAPEUTIC TARGET TARGETING HIV TRANSCRIPTION: THE QUEST FOR A FUNCTIONAL CURE TARGETING THE HIV RNA GENOME: HIGH-HANGING FRUIT ONLY NEEDS A LONGER LADDER HIV-1 GAG: AN EMERGING TARGET FOR ANTIRETROVIRAL THERAPY THE TRIPLE THREAT OF HIV-1 PROTEASE INHIBITORS ILLUSTRATIONS OF THE HIV LIFE CYCLE DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT. THE FUTURE OF HIV-1 THERAPEUTICS / TORBETT, BRUCE E. : 2015 ABSTRACT / INHALTSTEXT THIS VOLUME THOROUGHLY COVERS HIV-1 ANTIRETROVIRALS CURRENTLY IN CLINICAL USE, TOGETHER WITH THEIR ADVANTAGES AND LIMITATIONS. HIV-1 INHIBITOR RESISTANCE IS DISCUSSED IN DETAIL, AND CRITICAL ASSESSMENTS AS TO WHAT WILL BE REQUIRED OF FUTURE ANTIRETROVIRALS IN ORDER TO HALT VIRAL REPLICATION, REDUCE VIRAL RESISTANCE, AND ALTER THE STATE OF VIRAL LATENCY ARE PRESENTED. EXPERTS AT THE FOREFRONT OF HIV-1 RESEARCH PROVIDE OVERVIEWS OF APPROACHES FROM THE FIELDS OF VIROLOGY, CHEMICAL BIOLOGY AND STRUCTURAL BIOLOGY FOR OBTAINING SMALL MOLECULE INHIBITORS THAT TARGET VIRAL REGULATORY AND STRUCTURAL COMPONENTS AT MULTIPLE POINTS IN THE VIRAL LIFECYCLE. THE INDIVIDUAL CHAPTERS WILL APPEAL TO SCIENTISTS AND CLINICIANS ALIKE DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
any_adam_object	1
author_GND	(DE-588)172557968
building	Verbundindex
bvnumber	BV042544613
classification_tum	BIO 000
collection	ZDB-2-SBL
ctrlnum	(OCoLC)909073851 (DE-599)BVBBV042544613
dewey-full	616.9041
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	616 - Diseases
dewey-raw	616.9041
dewey-search	616.9041
dewey-sort	3616.9041
dewey-tens	610 - Medicine and health
discipline	Biologie Medizin
doi_str_mv	10.1007/978-3-319-18518-7
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02926nmm a2200637zcb4500</leader><controlfield tag="001">BV042544613</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150508 </controlfield><controlfield tag="007">cr\|uuu---uuuuu</controlfield><controlfield tag="008">150506s2015 \|\|\|\| o\|\|u\| \|\|\|\|\|\|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783319185187</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-319-18518-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-319-18518-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)909073851</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042544613</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield><subfield code="a">DE-703</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9041</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The Future of HIV-1 Therapeutics</subfield><subfield code="b">Resistance Is Futile?</subfield><subfield code="c">Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham [u.a.]</subfield><subfield code="b">Springer International Publishing</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 254 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Current Topics in Microbiology and Immunology</subfield><subfield code="v">389</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Emerging infectious diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiretrovirale Substanz</subfield><subfield code="0">(DE-588)4798688-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Antiretrovirale Substanz</subfield><subfield code="0">(DE-588)4798688-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Torbett, Bruce E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goodsell, David S.</subfield><subfield code="d">1961-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)172557968</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Richman, Douglas D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-3-319-18517-0</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Current Topics in Microbiology and Immunology</subfield><subfield code="v">389</subfield><subfield code="w">(DE-604)BV022782309</subfield><subfield code="9">389</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-319-18518-7</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Abstract</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2015</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027978619</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-18518-7</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-18518-7</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection>
genre	1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet	Aufsatzsammlung
id	DE-604.BV042544613
illustrated	Not Illustrated
indexdate	2024-07-10T01:24:34Z
institution	BVB
isbn	9783319185187
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-027978619
oclc_num	909073851
open_access_boolean
owner	DE-91 DE-BY-TUM DE-703
owner_facet	DE-91 DE-BY-TUM DE-703
physical	1 Online-Ressource (X, 254 p)
psigel	ZDB-2-SBL ZDB-2-SBL_2015
publishDate	2015
publishDateSearch	2015
publishDateSort	2015
publisher	Springer International Publishing
record_format	marc
series	Current Topics in Microbiology and Immunology
series2	Current Topics in Microbiology and Immunology
spelling	The Future of HIV-1 Therapeutics Resistance Is Futile? Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, ed. Cham [u.a.] Springer International Publishing 2015 1 Online-Ressource (X, 254 p) txt rdacontent c rdamedia cr rdacarrier Current Topics in Microbiology and Immunology 389 Medicine Drug interactions Medical virology Emerging infectious diseases Biomedicine Drug Resistance Virology Infectious Diseases Medizin Antiretrovirale Substanz (DE-588)4798688-8 gnd rswk-swf HIV-Infektion (DE-588)4203852-2 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content HIV-Infektion (DE-588)4203852-2 s Antiretrovirale Substanz (DE-588)4798688-8 s 2\p DE-604 Torbett, Bruce E. Sonstige oth Goodsell, David S. 1961- Sonstige (DE-588)172557968 oth Richman, Douglas D. Sonstige oth Erscheint auch als Druckausgabe 978-3-319-18517-0 Current Topics in Microbiology and Immunology 389 (DE-604)BV022782309 389 https://doi.org/10.1007/978-3-319-18518-7 Verlag Volltext Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Abstract 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle	The Future of HIV-1 Therapeutics Resistance Is Futile? Current Topics in Microbiology and Immunology Medicine Drug interactions Medical virology Emerging infectious diseases Biomedicine Drug Resistance Virology Infectious Diseases Medizin Antiretrovirale Substanz (DE-588)4798688-8 gnd HIV-Infektion (DE-588)4203852-2 gnd
subject_GND	(DE-588)4798688-8 (DE-588)4203852-2 (DE-588)4143413-4
title	The Future of HIV-1 Therapeutics Resistance Is Futile?
title_auth	The Future of HIV-1 Therapeutics Resistance Is Futile?
title_exact_search	The Future of HIV-1 Therapeutics Resistance Is Futile?
title_full	The Future of HIV-1 Therapeutics Resistance Is Futile? Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, ed.
title_fullStr	The Future of HIV-1 Therapeutics Resistance Is Futile? Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, ed.
title_full_unstemmed	The Future of HIV-1 Therapeutics Resistance Is Futile? Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, ed.
title_short	The Future of HIV-1 Therapeutics
title_sort	the future of hiv 1 therapeutics resistance is futile
title_sub	Resistance Is Futile?
topic	Medicine Drug interactions Medical virology Emerging infectious diseases Biomedicine Drug Resistance Virology Infectious Diseases Medizin Antiretrovirale Substanz (DE-588)4798688-8 gnd HIV-Infektion (DE-588)4203852-2 gnd
topic_facet	Medicine Drug interactions Medical virology Emerging infectious diseases Biomedicine Drug Resistance Virology Infectious Diseases Medizin Antiretrovirale Substanz HIV-Infektion Aufsatzsammlung
url	https://doi.org/10.1007/978-3-319-18518-7 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027978619&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA
volume_link	(DE-604)BV022782309
work_keys_str_mv	AT torbettbrucee thefutureofhiv1therapeuticsresistanceisfutile AT goodselldavids thefutureofhiv1therapeuticsresistanceisfutile AT richmandouglasd thefutureofhiv1therapeuticsresistanceisfutile

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge